Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Bauerlein Alison Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2023 4 Bauerlein Alison (See Remarks) has filed a Form 4 on Sight Sciences, Inc.
Txns: Granted 103,000 shares @ $0
Granted 71,800 options to buy @ $10.1, valued at $725.2k
04/05/2023 3 Bauerlein Alison (See remarks) has filed a Form 3 on Sight Sciences, Inc.
06/16/2022 4 Bauerlein Alison (Director) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Granted 100,000 restricted stock units @ $0
05/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2022 3 Bauerlein Alison (Director) has filed a Form 3 on GELESIS HOLDINGS, INC.
12/10/2021 4 Bauerlein Alison (Director) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Granted 115 options to buy @ $9.3, valued at $1.1k
12/07/2021 4 Bauerlein Alison (Director) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Granted 70,560 options to buy @ $9.3, valued at $656.2k
12/07/2021 3 Bauerlein Alison (Director) has filed a Form 3 on Pear Therapeutics, Inc.
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/03/2021 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Sold 8,235 shares @ $80.0149, valued at $658.9k
Sold 1,397 shares @ $80.3262, valued at $112.2k
Exercised 8,235 options to buy @ $38.54, valued at $317.4k
Exercised 1,397 options to buy @ $38.54, valued at $53.8k
07/29/2021 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Sold 9,632 shares @ $75.0171, valued at $722.6k
Exercised 9,632 options to buy @ $38.54, valued at $371.2k
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2021 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Sold 8,973 shares @ $50.0353, valued at $449k
Exercised 8,973 options to buy @ $0.81, valued at $7.3k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2020 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Sold 4,449 shares @ $39.439, valued at $175.5k
Sold 1,904 shares @ $40.42, valued at $77k
Sold 2,349 shares @ $41.33, valued at $97.1k
Exercised 8,702 options to buy @ $16.62, valued at $144.6k
12/02/2020 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 253 shares @ $35.28, valued at $8.9k
Paid exercise price by delivering 126 shares @ $35.28, valued at $4.4k
Paid exercise price by delivering 102 shares @ $35.28, valued at $3.6k
Paid exercise price by delivering 117 shares @ $35.28, valued at $4.1k
Exercised 253 restricted stock units @ $0
09/02/2020 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 252 shares @ $0
Paid exercise price by delivering 125 shares @ $28.94, valued at $3.6k
Paid exercise price by delivering 102 shares @ $28.94, valued at $3k
Paid exercise price by delivering 117 shares @ $28.94, valued at $3.4k
Exercised 252 restricted stock units @ $0
06/03/2020 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 253 shares @ $0
Paid exercise price by delivering 126 shares @ $38.55, valued at $4.9k
Paid exercise price by delivering 102 shares @ $38.55, valued at $3.9k
Paid exercise price by delivering 116 shares @ $38.55, valued at $4.5k
Exercised 253 restricted stock units @ $0
05/21/2020 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 8,737 restricted stock units @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2019 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 252 shares @ $0
Paid exercise price by delivering 125 shares @ $73.61, valued at $9.2k
Paid exercise price by delivering 102 shares @ $73.61, valued at $7.5k
Exercised 252 restricted stock units @ $0
09/04/2019 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 253 shares @ $0
Paid exercise price by delivering 127 shares @ $46.37, valued at $5.9k
Paid exercise price by delivering 103 shares @ $46.37, valued at $4.8k
Exercised 253 restricted stock units @ $0
08/27/2019 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Exercised 1,685 options to buy @ $0.75, valued at $1.3k
Exercised 2,315 options to buy @ $16.62, valued at $38.5k
06/04/2019 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 253 shares @ $0
Paid exercise price by delivering 126 shares @ $64.47, valued at $8.1k
Paid exercise price by delivering 102 shares @ $64.47, valued at $6.6k
Exercised 253 restricted stock units @ $0
03/05/2019 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Granted 3,739 shares @ $0
Granted 1,347 shares @ $0
Paid exercise price by delivering 466 shares @ $106.97, valued at $49.8k
Granted 1,417 shares @ $0
Paid exercise price by delivering 490 shares @ $106.97, valued at $52.4k
Granted 253 shares @ $0
Paid exercise price by delivering 88 shares @ $106.97, valued at $9.4k
Paid exercise price by delivering 284 shares @ $106.97, valued at $30.4k
Exercised 253 options to buy @ $0
12/06/2018 4 Bauerlein Alison (EVP, Finance, & CFO) has filed a Form 4 on Inogen Inc
Txns: Exercised 19,000 options to buy @ $8.37, valued at $159k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy